Research

SCANCA, Inc. is deeply committed to advancing research that aims to improve the health and lives of individuals with sickle cell disease. Through our dedicated partnerships with research organizations and groups, we lend our support and expertise to various initiatives focused on discovering new treatments and therapies. Our involvement ensures that we stay at the forefront of scientific advancements, allowing us to provide our community with the most current and effective care options. We are actively engaged in research activities, including participating in studies, supporting clinical trials, and collaborating with leading scientists and medical professionals.

Our commitment extends to informing and educating our clients and the broader community about the latest developments in sickle cell research. We ensure that our staff is well-versed in new treatments and therapies, such as gene therapy and bone marrow transplants, by attending conferences, engaging with pharmaceutical companies, and staying updated on medical journals and publications. By being actively involved in these discussions, we help shape the future of sickle cell treatment and advocate for the approval of innovative therapies. Through our research efforts, SCANCA, Inc. strives to enhance the quality of life for those affected by sickle cell disease and contribute to the global effort to find a cure.